CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 69 enrolled
Drug / intervention
Blood flow restriction therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04540367
NCT04540367N/ACompleted
CompareCT.gov

Blood Flow Restriction Training for The Shoulder: A Case for Proximal Benefit

The Methodist Hospital Research Institute·interventional·Posted Sep 7, 2020·Updated Aug 9, 2024

In Brief

A clinical study evaluating Blood flow restriction therapy for Healthy. Completed, enrolled 69 participants across 1 site.

Detailed Summary

The aim of this study is to determine if BFR-LIX promotes greater increases in shoulder lean mass, rotator cuff strength, endurance, and acute increases in shoulder muscle activation compared to LIX alone.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 7, 2020
Enrollment StartNov 10, 2017
Primary CompletionAug 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 5.8 years ago

Interventions

Blood flow restriction therapydevice

The study group underwent the same exercises as the control group modified by the use of a tourniquet for blood flow restriction during those exercises.